| Literature DB >> 30838037 |
Tianzhu Chao1,2, Zhuangzhuang Liu1,2, Yu Zhang1,2, Lichen Zhang1,2, Rong Huang1,2, Le He1,2, Yanrong Gu1,2, Zhijun Chen1,2, Qianqian Zheng1,2, Lijin Shi1,3, Wenping Zheng1,2, Xinhui Qi1,2, Eryan Kong1, Zhongjian Zhang1, Toby Lawrence4, Yinming Liang1,2,3, Liaoxun Lu1,2,3.
Abstract
It is a tempting goal to identify causative genes underlying phenotypic differences among inbred strains of mice, which is a huge reservoir of genetic resources to understand mammalian pathophysiology. In particular, the wild-derived mouse strains harbor enormous genetic variations that have been acquired during evolutionary divergence over 100s of 1000s of years. However, validating the genetic variation in non-classical strains was extremely difficult, until the advent of CRISPR/Cas9 genome editing tools. In this study, we first describe a T cell phenotype in both wild-derived PWD/PhJ parental mice and F1 hybrids, from a cross to C57BL/6 (B6) mice, and we isolate a genetic locus on Chr2, using linkage mapping and chromosome substitution mice. Importantly, we validate the identification of the functional gene controlling this T cell phenotype, Cd44, by allele specific knockout of the PWD copy, leaving the B6 copy completely intact. Our experiments using F1 mice with a dominant phenotype, allowed rapid validation of candidate genes by designing sgRNA PAM sequences that only target the DNA of the PWD genome. We obtained 10 animals derived from B6 eggs fertilized with PWD sperm cells which were subjected to microinjection of CRISPR/Cas9 gene targeting machinery. In the newborns of F1 hybrids, 80% (n = 10) had allele specific knockout of the candidate gene Cd44 of PWD origin, and no mice showed mistargeting of the B6 copy. In the resultant allele-specific knockout F1 mice, we observe full recovery of T cell phenotype. Therefore, our study provided a precise and rapid approach to functionally validate genes that could facilitate gene discovery in classic mouse genetics. More importantly, as we succeeded in genetic manipulation of mice, allele specific knockout could provide the possibility to inactivate disease alleles while keeping the normal allele of the gene intact in human cells.Entities:
Keywords: CD44; CRISPR/Cas9; allele specific knockout; functional genomics; wild mice
Year: 2019 PMID: 30838037 PMCID: PMC6390232 DOI: 10.3389/fgene.2019.00124
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1T cell phenotyping of B6 and PWD mice with splenocytes. For steady state analysis of splenocytes ex vivo, surface staining with antibodies labeling CD3 and TCRβ was used to define T cells in which CD4 and CD8 T cell subsets were further analyzed. For activated T cell analysis, in vitro stimulation with anti-CD3 and anti-CD28 was performed in total splenocytes. CD4 and CD8 T cells were analyzed for naïve and memory T cell frequencies in percentage and mean fluorescence intensity or MFI. (A) The gating method for T cells in the spleen of B6 and PWD mice. (B) Frequency of CD44lowCD62Lhigh cells (R1), CD44highCD62Lhigh cells (R2) and CD44highCD62Llow cells (R3) in CD4 T cells (CD4+CD8- cells) of B6 and PWD mice. (C) Frequency of CD44lowCD62Lhigh cells (R4) and CD44highCD62Lhigh cells (R5) in CD8 T cells (CD4-CD8+ cells) of B6 and PWD mice. (D) MFI of CD44 in CD4 T cells of B6 and PWD mice, FMO control was used as negative control by staining all the surface labeling antibodies except CD44. (E) MFI of CD44 in CD8 T cells of B6 and PWD mice, FMO control was used as negative control by staining all the surface labeling antibodies except CD44. (F) The gating method for immune cells in the spleen of B6 and PWD mice after anti-CD3 (3 μg/mL, coated) and anti-CD28 (1 μg/mL, soluble) stimulation. (G) Frequency of CD44highCD62Llow cells in CD4 T cells (R6) and CD8 T cells (R7) of B6 and PWD mice after anti-CD3 (3 μg/mL, coated) and anti-CD28 (1 μg/mL, soluble) stimulation. (H) MFI of CD44 in CD4 T cells of B6 and PWD mice after anti-CD3 (3 μg/mL, coated) and anti-CD28 (1 μg/mL, soluble) stimulation. (I) MFI of CD44 positive cells in CD8 T cells of B6 and PWD mice after anti-CD3 (3 μg/mL, coated) and anti-CD28 (1 μg/mL, soluble) stimulation. Representative FACS data were from two independent experiments involving at least six animals for each group of mice. Data were analyzed by two-tailed Student’s t-test. Data were presented as Mean ± SEM. ∗p < 0.05, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
FIGURE 2T cell phenotyping of B6, PWD and F1 mice for spleen and thymus. For peripheral T cell analysis, splenocytes were analyzed ex vivo for CD44 and CD62L expression in CD4 T cells. For thymocytes analysis, CD4 and CD8 T single positive T cells and their precursors namely CD4 and CD8 double positive and double negative cells were analyzed. Inside the double negative compartment, further analysis with CD25 and CD44 were used to define each precursor population. (A) The gating method for T cells in the spleen of B6, PWD and F1 mice. (B) Frequency of CD44lowCD62Lhigh cells (R1) and CD44highCD62Lhigh cells (R2) in CD4+CD8- cells of B6, PWD and F1 splenocytes. (C) Overlay of CD44 MFI in CD4 T cells of B6, PWD and F1 splenocytes, FMO control was used as negative control by staining all the surface labeling antibodies except CD44. (D) The gating method for immune cells in the thymus of B6, PWD and F1 mice. (E) Absolute thymocyte count of B6, PWD and F1 mice. (F) Frequency of DN1-DN4 cells in DN cells of B6, PWD and F1 thymocytes. (G) MFI of CD44 positive cells in DN, DP, CD4+ SP and CD8+ SP cells of B6, PWD and F1 thymocytes. Representative FACS data were from two independent experiments involving at least seven animals for each group of mice. Data were analyzed by two-tailed Student’s t-test. Data were presented as Mean ± SEM. ∗∗p < 0.01, ∗∗∗∗p < 0.0001.
FIGURE 3Genome-wide scanning to map QTL influencing the CD4 T phenotype. The dominant phenotype of CD4 T cells was used to categorize mice with PWD phenotype or B6 phenotype by absence or presence of the “naïve” T cells which were CD44lowCD62Lhigh (refer to Figure 2A, R1). (A) The genetic maker distribution throughout the mouse genome to analyze N2 population with 120 STRs. (B) LOD score curves of the initial mapping with 68 animals (37 phenotypic mice, and 31 non-phenotypic mice), and chromosome 1–19 were represented numerically on the X-axis. The relative width of the space allotted for each chromosome reflects the number of microsatellite markers typed for that chromosome. The Y-axis represents the LOD score. The horizontal dashed lines denote genome-wide empirical thresholds for significant (p = 0.05) linkage. (C) Interval mapping identified one major QTL in the position from 47.42 to 66.42 cM on mouse chromosome 2. (D) Fine-mapping of the major Chr2 QTL in an N2 population of 491 individuals. Open box denotes B6 genotype of the STR markers, and filled box represents PWD genotype. “0” was used to represents B6 phenotype and “1” for PWD phenotype. Inside the fine mapped interval between D2Mit300 and D2Mit127, candidate genes were listed.
FIGURE 4Generation and genotyping of PWD CD44 allele specific knockout in F1 mice. (A) The distribution of SNPs in Cd44 exons of the whole genome sequenced PWK strain which is a close relative of PWD strain. (B) Two PAM sequences (5′-NGG-3′) that only existed in the PWD mice were selected and confirmed by Sanger sequencing. (C) SgRNA sequences in Cd44 exon5 and exon12 which were selected for allele specific knockout. (D) Workflow of producing PWD CD44 allele specific knockout in F1 mice. (E) Efficiency of CRISPR/Cas9 system in specific inactivation of CD44 from PWD origin. (F) The genotyping of F1-CD44 mice by using capillary electrophoresis analysis (left) and Sanger sequencing (right).
FIGURE 5Immunophenotyping of T cells in splenocytes of F1 and F1-CD44 mice. In the F1 mice, consequence of the allele specific knockout of CD44 was analyzed by assessing the alteration of phenotype which was observed in PWD parental strain. (A) The gating method for T cells in the spleen of F1 and F1-CD44 mice. (B) Frequency of CD44lowCD62Lhigh cells (R1) and CD44highCD62Lhigh cells (R2) in CD4+CD8- cells of F1 and F1-CD44 mice. (C) Frequency of CD44lowCD62Lhigh cells (R3) and CD44highCD62Lhigh cells (R4) in CD4-CD8+ cells of F1 and F1-CD44 mice. (D) MFI of CD44 positive cells in CD4+ cells of F1 and F1-CD44 mice. (E) MFI of CD44 positive cells in CD8+ cells of F1 and F1-CD44 mice. Representative FACS data were from two independent experiments involving at least six mice for each genotype. Data were analyzed by two-tailed Student’s t-test. Data were presented as Mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.